Domains of Structured Oral Anticancer Medication Programs: A Scoping Review.
Kapeena Sivakumaran, Pamela K Ginex, Haya Waseem and 6 others
PMID 35788732WHAT IT FOUND
Structured oral anticancer medication programs commonly combine education, counseling, follow-up, clinician contact, toxicity and adherence monitoring, drug supply, cost help, technology, and risk assessment.
The review does not show which parts improve adherence.
Key findings
01The review included 21 studies reporting on distinct structured oral anticancer medication programs.
02Follow-up, education, adherence monitoring, and adverse event and toxicity monitoring were identified in 70% (n = 14) of the programs.
03The review did not evaluate program effectiveness, and it is unknown which components are most crucial to optimal adherence.
STILL TO COME
How it was doneWhat they foundWhat it means for RNs
Read the rest of this summary
You get three full summaries a month, free, and we do not ask for a card. Search, the TL;DRs and your library stay unlimited either way.
What it does not show
The scoping review did not assess the quality of the included studies. The included studies were mainly observational cohorts, so they cannot establish whether programs work. Programs varied in setting, population, adherence phase, and components. Direct comparison is difficult. The proposed framework was developed through iterative expert review and may not be easily replicable. Which components are most crucial remains unknown. The paper gives inconsistent counts for included studies and distinct programs.
Declared interests
The supplied article metadata lists non-U.S. government and NIH extramural research support. No author conflict-of-interest declaration is included in the supplied text.
The easy way to misread this
Do not read the component framework as proof that oral anticancer medication programs improve adherence. The review mapped what programs included, did not assess study quality, and did not test program effectiveness.